Citation Impact
Citing Papers
Phase I trial of temozolomide using an extended continuous oral schedule.
1998
Polymeric Micelles in Anticancer Therapy: Targeting, Imaging and Triggered Release
2010
Solubilisation of [60]fullerenes using block copolymers and evaluation of their photodynamic activities
2008
Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial
2012
Disassemblable micelles based on reduction-degradable amphiphilic graft copolymers for intracellular delivery of doxorubicin
2010
Mesoporous silica nanoparticles in biomedical applications
2012 StandoutNobel
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
Quality assurance of the EORTC 26981/22981; NCIC CE3 intergroup trial on radiotherapy with or without temozolomide for newly-diagnosed glioblastoma multiforme: the individual case review
2004
Targeted polymeric therapeutic nanoparticles: design, development and clinical translation
2012
PEO-PPO Block Copolymers for Passive Micellar Targeting and Overcoming Multidrug Resistance in Cancer Therapy
2011
Glioblastoma and Other Malignant Gliomas
2013 Standout
Involvement of the TIP60 Histone Acetylase Complex in DNA Repair and Apoptosis
2000 Standout
Nanoparticle therapeutics: an emerging treatment modality for cancer
2008 Standout
Rapid translocation of nanoparticles from the lung airspaces to the body
2010 StandoutNobel
Stimuli-responsive nanocarriers for drug delivery
2013 Standout
Cytotoxicity and internalization of Pluronic micelles stabilized by core cross-linking
2014
Nanocarriers as an emerging platform for cancer therapy
2007 Standout
Survival of human glioma cells treated with various combination of temozolomide and X-rays
2000
Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
2014 Standout
Polymer conjugates as anticancer nanomedicines
2006 Standout
The use of ultrasound to release chemotherapeutic drugs from micelles and liposomes
2014
Design considerations for tumour-targeted nanoparticles
2009 StandoutNobel
Polymeric micelles for drug targeting
2007
Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials
1997
Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse
2001
Fluorescent Nanorods and Nanospheres for Real‐Time In Vivo Probing of Nanoparticle Shape‐Dependent Tumor Penetration
2011 StandoutNobel
Malignant Gliomas in Adults
2008 Standout
Tumor delivery of macromolecular drugs based on the EPR effect
2010 Standout
Strategies in the design of nanoparticles for therapeutic applications
2010 Standout
Prodrug activation enzymes in cancer gene therapy
2000
A phase 2 study of SP1049C, doxorubicin in P-glycoprotein-targeting pluronics, in patients with advanced adenocarcinoma of the esophagus and gastroesophageal junction
2010
Neuroblastoma
2007 Standout
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
2005 Standout
Primary brain tumours in adults
2012 Standout
Pluronic block copolymers alter apoptotic signal transduction of doxorubicin in drug-resistant cancer cells
2005
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
2010 Standout
Multifunctional polymeric micelles for delivery of drugs and siRNA
2014
Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner
2012 StandoutNobel
Brain Tumors
2001 Standout
Functionalized Micellar Systems for Cancer Targeted Drug Delivery
2007
Cancer Cell Invasion: Treatment and Monitoring Opportunities in Nanomedicine
2011
Passive and Active Drug Targeting: Drug Delivery to Tumors as an Example
2009
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Biochemical Modulation of Cisplatin Mechanisms of Action: Enhancement of Antitumor Activity and Circumvention of Drug Resistance
2003 Standout
Photoexpulsion of Surface-Grafted Ruthenium Complexes and Subsequent Release of Cytotoxic Cargos to Cancer Cells from Mesoporous Silica Nanoparticles
2013 StandoutNobel
Antitumor activity of imidazole derivatives: dacarbazine and the new alkylating agent imidazene (Review)
2010
Azole-Based Energetic Salts
2011 Standout
One-Component Multifunctional Sequence-Defined Ionizable Amphiphilic Janus Dendrimer Delivery Systems for mRNA
2021 StandoutNobel
Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications
2008 Standout
Bioreducible Carboxymethyl Dextran Nanoparticles for Tumor‐Targeted Drug Delivery
2014
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma
2000
Phase I Trial of Temozolomide and Protracted Irinotecan in Pediatric Patients with Refractory Solid Tumors
2004
Functional Nanomaterials for Phototherapies of Cancer
2014 Standout
DNA Mismatch Repair: Functions and Mechanisms
2005 StandoutNobel
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
The p38 Mitogen-Activated Protein Kinase Pathway Links the DNA Mismatch Repair System to the G2 Checkpoint and to Resistance to Chemotherapeutic DNA-Methylating Agents
2003
Nanoparticles in Photodynamic Therapy
2015 Standout
Benefit of Temozolomide Compared to Procarbazine in Treatment of Glioblastoma Multiforme at First Relapse: Effect on Neurological Functioning, Performance Status, and Health Related Quality of Life
2005
Plasmons in Strongly Coupled Metallic Nanostructures
2011 Standout
Direct evidence for the participation of gap junction-mediated intercellular communication in the transmission of damage signals from alpha -particle irradiated to nonirradiated cells
2001 Standout
Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform
2011 Standout
Carbon Nanomaterials for Biological Imaging and Nanomedicinal Therapy
2015 Standout
Multistage nanoparticle delivery system for deep penetration into tumor tissue
2011 StandoutNobel
Nanoparticle Size and Surface Chemistry Determine Serum Protein Adsorption and Macrophage Uptake
2011 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Light-Controlled Radical Polymerization: Mechanisms, Methods, and Applications
2016 Standout
Overcoming the Blood–Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases
2018
Core/Shell Nanoparticles: Classes, Properties, Synthesis Mechanisms, Characterization, and Applications
2011 Standout
Safety and Efficacy of Temozolomide in Patients With Recurrent Anaplastic Oligodendrogliomas After Standard Radiotherapy and Chemotherapy
2001
Metal–Organic Frameworks in Biomedicine
2011 Standout
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
pH-Operated Nanopistons on the Surfaces of Mesoporous Silica Nanoparticles
2010 StandoutNobel
Synthesis and Characterization of Thermally Responsive Pluronic F127−Chitosan Nanocapsules for Controlled Release and Intracellular Delivery of Small Molecules
2010
High rate of CAD gene amplification in human cells deficient in MLH1 or MSH6
2001 StandoutNobel
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Tissue- and Organ-Selective Biodistribution of NIR Fluorescent Quantum Dots
2009 StandoutNobel
hMutSα- and hMutLα-dependent phosphorylation of p53 in response to DNA methylator damage
1999 StandoutNobel
Multicenter Phase II Trial of Temozolomide in Patients With Anaplastic Astrocytoma or Anaplastic Oligoastrocytoma at First Relapse
1999
A new resistance mechanism to cisplatin?
2000
Multifunctional Polymeric Micelles as Cancer-Targeted, MRI-Ultrasensitive Drug Delivery Systems
2006
Involvement of the Mismatch Repair System in Temozolomide-Induced Apoptosis
1998
pH-Responsive Copolymer Assemblies for Controlled Release of Doxorubicin
2005
Clinical Translation of Nanomedicine
2015
Works of M Brampton being referenced
Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer
2004
Temozolomide: A new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumours
1993
Cancer Research Campaign phase II trial of temozolomide in metastatic melanoma.
1995